NRx Pharmaceuticals (NASDAQ: NRXP) announced it has received a letter from the FDA Office of Generic Drugs indicating only minor formatting comments on the proposed label for its preservative-free ketamine product, with a final label submission expected this month and potential approval of its Abbreviated New Drug Application anticipated in Summer 2026 pending final review. The […]

Datavault AI (NASDAQ: DVLT) announced that CEO Nathaniel T. Bradley will present and exhibit the Company’s DataValue(R), DataScore(R), Data Vault Bank(R) AI Agent and Information Data Exchange(R) technologies at XRP Tokyo 2026 on April 7, 2026, highlighting its AI-powered infrastructure for real-world asset tokenization as it targets Japan’s rapidly expanding, regulation-friendly market and broader APAC […]

Soligenix (NASDAQ: SNGX) announced the publication of positive results from its comparability study evaluating HyBryte(TM) versus Valchlor(R) for the treatment of cutaneous T-cell lymphoma in Oncology and Therapy, highlighting favorable efficacy and safety outcomes. After 12 weeks, 60% of HyBryte-treated patients achieved treatment success compared to 20% for Valchlor, with greater average improvement and no treatment-related adverse events reported for HyBryte, while Valchlor patients experienced multiple adverse […]

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising. Rare earth elements have become one of the most strategically important groups of materials in the modern global economy, underpinning technologies that range from electric vehicles to advanced defense systems. As demand accelerates and supply remains heavily concentrated […]

Datavault AI (NASDAQ: DVLT), an AI-driven data monetization, RWA tokenization and Web 3.0 infrastructure company, and Demora Foundation announced a Technology Integration Agreement naming Datavault AI as the formal AI data intelligence and RWA tokenization technology partner for the K-Entertainment & K-Wave Global Platform, spanning Atlanta, Dallas and the New York Tri-State area. Under the […]

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) and may include paid advertising. CMX (CSE: CXC) (OTC: CXXMF), an exploration-stage company, is moving forward with the exploration of its flagship Clayton Silver project in Idaho. The 1,028-acre property holds 29 patented mining claims, 2 patented mill sites, and 20 unpatented claims. “The […]

Massimo Group (NASDAQ: MAMO) reported financial results for the fiscal year ended Dec. 31, 2025, highlighting a significant expansion in gross margin to approximately 37.5% from 29.7% in 2024, driven by product mix optimization and cost efficiencies. While revenue declined to $71.8 million as the company rebalanced dealer inventory and prioritized pricing discipline, Massimo maintained profitability with $1.5 million in net income […]

ParaZero Technologies (NASDAQ: PRZO) announced it has signed a framework agreement with a Tier-1 international company specializing in autonomous drone interception, including integration of its DefendAir Net Pod into the client’s new drone platform. The agreement includes a minimum purchase of 2,000 customized units and is expected to expand global deployment of ParaZero’s Counter-UAS solutions while enhancing drone interception capabilities. To view the […]

The publication of clinical research in peer-reviewed journals remains a critical milestone in drug development, offering independent validation and broader visibility for emerging therapies. Soligenix (NASDAQ: SNGX) recently reached such a milestone with the publication of a clinical summary of its HyBryte(TM) therapy, reinforcing the importance of scientific transparency as the company advances treatments for rare diseases. Publishing research […]

Rail Vision (NASDAQ: RVSN) reported financial results for the second half and full year ended Dec. 31, 2025, citing revenue growth and continued operational progress as it expands its global footprint. The company advanced deployments with Israel Railways, secured follow-on orders in Latin America, expanded into Central America and launched a proof of concept in India, underscoring increasing adoption of […]

LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced it has filed its Annual Report on Form 10-K for the year ended Dec. 31, 2025, outlining a year marked by leadership changes, clinical progress and strategic expansion. The company advanced development of its lead compound LB-100, expanded clinical trials with additional sites and increased enrollment, completed the acquisition of Liora Technologies Europe Ltd. to enhance […]

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising. Securing reliable supplies of specialized rare earth elements is becoming increasingly important as demand rises across defense, energy and advanced manufacturing sectors. With this in mind, Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) recently announced that it is […]